-
22 Dec, 2009 10:48 CET
MOBERG DERMA AB
MOBERG DERMA CLOSED TRANCHE 2 OF FINANCING
Moberg Derma
-
20 Nov, 2009 14:05 CET
MOBERG DERMA AB
MOBERG DERMA REPORTS POSITIVE PHASE II RESULTS FOR K201 AGAINST ATOPIC ECZEMA
Moberg Derma
,
K201
,
positive results
,
clinical trial
,
atopic eczema
,
phase II
,
dermatology
,
significant
-
18 Nov, 2009 13:30 CET
MOBERG DERMA AB
MOBERG DERMA RECEIVES GRANT FROM VINNOVA FOR PHARMACEUTICAL PROJECT
Moberg Derma
,
anti-fungal
,
dermatology
,
Vinnova
,
pharmaceutical
,
antifungals
,
grant
,
patent-protected
-
24 Aug, 2009 08:00 CET
MOBERG DERMA AB
MOBERG DERMA SECURED SEK 35 MILLION IN NEW SHARE ISSUE
Moberg Derma
,
nail fungus
,
onychomycosis
,
nail
,
phase III
,
positive results
,
anti-fungal
,
fungal
,
dermatology
,
investors
,
new share issue
,
shareholders
-
27 Feb, 2009 10:15 CET
MOBERG DERMA AB
MOBERG DERMA SIGNS COMMERCIAL AGREEMENT FOR NAIL FUNGUS PRODUCT K101 WITH LEADING NORDIC OTC COMPANY
Moberg Derma
,
K101
,
nail fungus
,
onychomycosis
,
partner
,
OTC
,
royalty
,
market organisation
,
commercial agreement
,
licens agreement
,
Nordic region
-
27 Feb, 2009 10:15 CET
MOBERG DERMA AB
MOBERG DERMA ENTERS LICENSE AND DISTRIBUTION AGREEMENT WITH MEDPHARM
Moberg Derma
,
royalty
,
MedPharm
,
Kaprolac
,
MedSpray
,
dermatology
,
collaboration
,
synergies
,
licensagreement
,
formulation technology
,
product development
-
27 Feb, 2009 10:15 CET
MOBERG DERMA AB
MOBERG DERMA ACQUIRES PHARMACEUTICAL PROJECTS FROM ZELMIC
innovation
,
Moberg Derma
,
Zelmic
,
dermatology
,
collaboration
,
synergies
,
pharmaceutical projects
,
acquisition
-
9 Dec, 2008 11:30 CET
MOBERG DERMA AB
MOBERG DERMA RECRUITS SALES & MARKETING DIRECTOR
Moberg Derma
,
K101
,
K201
,
K301
,
nail fungus
,
phase III
,
atopic dermatitis
,
seborrheic dermatitis
,
Sales & Marketing
,
Sales and Marketing
,
recruits
,
sales organisation
,
commercial
,
market
,
phase II
-
20 Nov, 2008 14:50 CET
MOBERG DERMA AB
MOBERG DERMA REPORTS POSITIVE PHASE III RESULTS FOR K101 AGAINST NAIL FUNGUS
Moberg Derma
,
K101
,
K201
,
K301
,
trichophyton
,
nail fungus
,
onychomycosis
,
nail
,
phase III
,
positive results
,
clinical trial
,
clinical study
,
dermatophytes
,
mycological cure
,
fungal culture
,
anti-fungal
,
atopic dermatitis
,
atopic eczema
,
seborrheic dermatitis
,
seborrheic eczema
,
fungal
,
fungus
-
18 Aug, 2008 08:00 CET
MOBERG DERMA AB
Moberg Derma reports promising phase III clinical results for its product candidate K301 against seborrheic dermatitis